Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)

Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)

  • Koncept Analytics
  • March 2018
  • Pharmaceutical
  • 68 pages

Report Description


Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Disorder. Further Lipid Metabolism Disorder is categorized into Gaucher disease & Fabry disease and Glycoprotein Metabolism Disorder into Pompe disease. LSD develops mainly due to deficiency of lysosomal enzyme in the living body. A person suffering from LSD could experience problems like abnormal growth of bones, delay movement of body, deafness, blindness, dementia, respiratory problems, fatigue/weakness, bone & joint deformity, organ enlargement, lung dysfunction, severe & fatal physical & mental health deterioration.

The global LSD market is expected to grow with growing Ashkenazi (Eastern and Western Europe) population, increasing pharmaceutical R&D spending, growing disposable income, rising healthcare expenditure and accelerating economic growth. Key trends of this rare disease market includes progressing drugs under pipeline and increasing preference towards gene therapy. However, there are some factors which can hinder growth of the market including stringent regulations and limited access to patent rights.

The report “Global Lysosomal Storage Disease (LSD) Market (Fabry, Gaucher & Pompe): Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook.

The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the global market. The report profiles the key players of the market including Pfizer Inc., Sanofi S.A., Shire Plc and Protalix BioTherapeutics, Inc.

Have query on this report?

Make an Enquiry

Table of Content

1. Market Overview
1.1 Lysosomal Storage Disease (LSD)
1.2 Classification of LSD
1.3 Symptoms
1.4 Diagnosis
1.5 Treatment
1.6 Upcoming Treatment

2. 2. Global LSD Market Analysis
2.1 Global LSD Market Forecast by Value
2.2 Global LSD Market Value by Category
2.3 Global Fabry Disease Market Forecast by Value
2.4 Global Fabry Disease Market Value by Drugs 
2.4.1 Global Fabrazyme Sales Value
2.4.2 Global Replagal Sales Value
2.4.3 Global Galafold Sales Value
2.5 Global Gaucher Disease Market Forecast by Value
2.6 Global Gaucher Disease Market Value by Drugs
2.6.1 Global Cerezyme Sales Value
2.6.2 Global Vipriv Sales Value
2.6.3 Global Cerdelga Sales Value
2.7 Global Pompe Disease Market Forecast by Value
2.8 Global Pompe Disease Market Value by Drugs
2.8.1 Global Myozyme Sales Value

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Growing Ashkenazi (Eastern and Western Europe) Population
3.1.2 Rising Pharmaceutical R&D Spending
3.1.3 Increasing Disposable Income
3.1.4 Growing Healthcare Expenditure
3.1.5 Accelerating Economic Growth
3.2 Key Trends & Developments
3.2.1 Progressing Drugs under Pipeline
3.2.2 Increasing Preference towards Gene Therapy
3.3 Challenges
3.3.1 Stringent Regulations
3.3.2 Limited Access to Patent Rights

4. Competitive Landscape
4.1 Global Market
4.1.1 Revenue Comparison of Key Players
4.1.2 Market Cap Comparison of Key Players
4.1.3 Global LSD Market-Annual Treatment Cost Comparison by Company

Drugs under Development for Lysosomal Storage Disease (2017)
Global LSD Market Key Players - Revenue Comparison (2017)
Global LSD Market-Annual Treatment Cost Comparison by Company (2017)
Pfizer Inc. Significant Agreements (2017/2018) 
Sanofi S.A. Significant Acquisitions (2017/2018) 
Protalix BioTherapeutics, Inc. Product Pipeline (2017)

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.


get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074